肝脏 ›› 2024, Vol. 29 ›› Issue (2): 157-161.

• 肝纤维化及肝硬化 • 上一篇    下一篇

伴自发性门静脉分流孤立性静脉曲张破裂出血患者临床特点

翁成钊, 王超, 张峻, 林思慧, 林冲, 陈世耀, 蒋炜   

  1. 361000 福建 复旦大学附属中山医院厦门医院消化科(翁成钊,王超,张峻,林思慧),放射科(林冲);200032 上海 复旦大学附属中山医院消化科(陈世耀,蒋炜)
  • 收稿日期:2023-09-08 出版日期:2024-02-29 发布日期:2024-03-18
  • 通讯作者: 蒋炜,Email: jiang.wei@zs-hospital.sh.cn
  • 基金资助:
    福建省自然科学基金重点项目(2021D033),福建省医学创新课题(2022CXB020),厦门市医疗卫生指导性项目(3502Z20209046)

The clinical characteristics of patients with spontaneous portalsystemic shunt and isolated gastric variceal bleeding

WENG Cheng-zhao1, WANG Chao1, ZHANG Jun1, LIN Si-hui1, LIN Chong2, CHEN Shi-yao3, JIANG Wei3   

  1. 1. Department of Gastroenterology and Hepatology, Zhongshan Hospital(Xiamen Branch) Affiliated to Fudan University, Fujian 361000, China;
    2. Department of Radiology, Zhongshan Hospital(Xiamen Branch) Affiliated to Fudan University, Fudan University, Fujian 361000, China;
    3. Department of Gastroenterology, Zhongshan Hospital Affiliated to Fudan University,Shanghai 200032, China
  • Received:2023-09-08 Online:2024-02-29 Published:2024-03-18
  • Contact: JIANG Wei, Email: jiang.wei@zs-hospital.sh.cn

摘要: 目的 了解伴自发性门静脉分流(SPSS)的孤立性静脉曲张(IGV-1)破裂出血患者的临床特点。方法 回顾性分析伴SPSS的IGV-1破裂出血患者,记录不同的类型的SPSS患者门静脉直径、门静脉压力梯度(HVPG)、门静脉有无血栓、Child-Pugh评分、Meld评分、治疗方式,随访3年,记录术后再出血次数及生存情况。结果 纳入IGV-1破裂出血患者37例,15例存在脾肾分流道,14例存在胃肾分流道,8例同时存在脾肾分流和胃肾分流。18例进行TIPS治疗,随访中出现再出血4例,肝性脑病4例;胃冠状静脉栓塞术联合部分脾栓塞术治疗6例,随访中再出血4例,死亡1例。内镜治疗患者9例,随访中再出血3例,肝性脑病1例,死亡1例。单因素Cox回归发现门静脉血栓(PVT)和HVPG是影响患者再出血的危险因素。结论 伴SPSS的IGV-1患者再出血、腹水和PVT发生率较高,同时PVT和HVPG是再出血的危险因素,分流形式对IGV-1治疗方案的选择有重要价值。

关键词: 自发性门静脉分流, 孤立性静脉曲张, 门静脉血栓, 门静脉高压

Abstract: Objective To analyze the clinical characteristics of patients with spontaneous portalsystemic shunt and isolated gastric variceal bleeding. Methods A retrospective study was performed on the patients with spontaneous portalsystemic shunt (SPSS) and bleeding caused by isolated gastric varices type 1 (IGV-1). The portal vein diameter, Hepatic Venous Pressure Gradient (HVPG), portal vein thrombosis (PVT), Child Pugh score, MELD score and treatment method of different types of SPSS patients were recorded. The patients were followed up for 3 years, and recorded the number of bleedings and their survival rate. Results A total of thirty- seven patients were included in this study, including 15 patients with splenorenal shunt, 14 patients with gastrorenal shunt, and 8 patients with both splenorenal shunt and gastrorenal shunt. During the follow-up period of time, within 18 patients who were treated with transjugular intrahepatic portosystomic stent shunt (TIPS), 4 cases (22.2%) each occured rebleeding and hepatic encephalopathy. Six cases were treated with gastric coronary vein embolization combined with partial splenic embolization. Within them, 4 cases of rebleeding and 1 case of death occurred during the follow-up. Nine cases accepted endoscopic treatment. Within them, 3 cases (33.3%) had rebleeding, 1 patient (11.1%) had hepatic encephalopathy, and 1 case (11.1%) died during the follow-up. Univariate Cox regression analysis showed that PVT and the level of HVPG were risk factors for rebleeding. Conclusion The incidences of rebleeding, ascites and PVT in patients with SPSS and IGV-1 are high. PVT and the level of HVPG are risk factors associated with rebleeding. The form of shunt has important value for the selection of IGV-1 treatment options.

Key words: Spontaneous portal systemic shunt, Isolated gastric varices type 1, Portal vein thrombosis, Portal hypertension